نتائج البحث - "Sara Durland-Busbice"

1

Supplementary Figure 2 from Efficacy of Low-Dose Oral Metronomic Dosing of the Prodrug of Gemcitabine, LY2334737, in Human Tumor Xenografts

المؤلفون: Anne H. Dantzig, Everett J. Perkins, Enaksha R. Wickremsinhe, James J. Starling, Gregory P. Donoho, Robert L. Shepard, Sara Durland–Busbice, Susan E. Pratt

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b26de16f0ee5d751321264d9d15621d
https://doi.org/10.1158/1535-7163.22498848

View record in OpenAIRE

2

Supplementary Figure 1 from Efficacy of Low-Dose Oral Metronomic Dosing of the Prodrug of Gemcitabine, LY2334737, in Human Tumor Xenografts

المؤلفون: Anne H. Dantzig, Everett J. Perkins, Enaksha R. Wickremsinhe, James J. Starling, Gregory P. Donoho, Robert L. Shepard, Sara Durland–Busbice, Susan E. Pratt

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b531576d023873277f8bbc6e15fa91
https://doi.org/10.1158/1535-7163.22498851

View record in OpenAIRE

3

Supplementary Figure Legend from Efficacy of Low-Dose Oral Metronomic Dosing of the Prodrug of Gemcitabine, LY2334737, in Human Tumor Xenografts

المؤلفون: Anne H. Dantzig, Everett J. Perkins, Enaksha R. Wickremsinhe, James J. Starling, Gregory P. Donoho, Robert L. Shepard, Sara Durland–Busbice, Susan E. Pratt

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b0837c46c6fb9854d5f51893366d9a
https://doi.org/10.1158/1535-7163.22498845.v1

View record in OpenAIRE

4

A phase Ia/Ib, dose-escalation/expansion study of the MDM2–p53 antagonist BI 907828 in patients with solid tumors, including advanced/metastatic liposarcoma (LPS)

المؤلفون: Mrinal M. Gounder, Noboru Yamamoto, Manish R. Patel, Todd Michael Bauer, Patrick Schöffski, Rolf Grempler, Sara Durland-Busbice, Junxian Geng, Angela Maerten, Patricia LoRusso

المصدر: Journal of Clinical Oncology. 40:3004-3004

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e60aa9e0e08ddb7c7ca1d290d7b2adc5
https://doi.org/10.1200/jco.2022.40.16_suppl.3004

View record in OpenAIRE

5

Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells

المؤلفون: Philip W. Iversen, Anne H. Dantzig, Susan E. Pratt, Robert L. Shepard, Sara Durland-Busbice, Kathleen M. Heinz-Taheny

المصدر: Clinical Cancer Research. 19:1159-1168

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae27476ae67701ca4753cba10e5a1921
https://doi.org/10.1158/1078-0432.ccr-12-1184

View record in OpenAIRE

6

Abstract A108: LY2606368, a second generation Chk1 inhibitor, inhibits growth of ovarian carcinoma xenografts either as monotherapy or in combination with standard-of-care agents

المؤلفون: Darlene S. Barnard, Aimee K. Bence, Richard P. Beckmann, Mark S. Marshall, Sara Durland-Busbice, Teresa F. Burke, Samuel McNeely

المصدر: Molecular Cancer Therapeutics. 10:A108-A108

مصطلحات موضوعية: Cisplatin, Cancer Research, Cell cycle checkpoint, DNA damage, Cancer, Biology, Pharmacology, medicine.disease, Ovarian tumor, chemistry.chemical_compound, Oncology, Paclitaxel, chemistry, medicine, Growth inhibition, Ovarian cancer, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4e1eaad71acf29cb5ae1a8dea9aceb69
https://doi.org/10.1158/1535-7163.targ-11-a108

View record in OpenAIRE

7

Abstract B30: Altered response to the prodrug of gemcitabine LY2334737 by overexpression or knockdown of carboxylesterase 2 (CES2)

المؤلفون: Philip W. Iversen, Robert L. Shepard, Susan E. Pratt, Lisa Kays, Kathleen M. Heinz-Taheny, Darryl Ballard, Sara Durland-Busbice, Anne H. Dantzig

المصدر: Clinical Cancer Research. 16:B30-B30

مصطلحات موضوعية: Cancer Research, Transfection, Cell cycle, Prodrug, Biology, Molecular biology, Gemcitabine, Small hairpin RNA, chemistry.chemical_compound, Oncology, chemistry, Cell culture, In vivo, medicine, Growth inhibition, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e40accd2417e33347c729588b57e1522
https://doi.org/10.1158/1078-0432.tcmusa10-b30

View record in OpenAIRE

8

Abstract B36: Identification of carboxylesterase 2 as a hydrolase that cleaves the prodrug of gemcitabine LY2334737

المؤلفون: Sara Durland-Busbice, Robert L. Shepard, Anne H. Dantzig, Darryl Ballard, Kathleen M. Heinz-Taheny, Harry B. Harlow, Susan E. Pratt

المصدر: Clinical Cancer Research. 16:B36-B36

مصطلحات موضوعية: Cancer Research, Chemistry, Carboxylesterase 1, Prodrug, Pharmacology, Gemcitabine Hydrochloride, Gemcitabine, Carboxylesterase, Oncology, Cell culture, Cancer cell, medicine, Cytotoxicity, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a8ace58559aff4e37e28ef12bdf4e4b5
https://doi.org/10.1158/1078-0432.tcmusa10-b36

View record in OpenAIRE

تنقيح النتائج